Correction to: “Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial”

Ashina M, Tepper SJ, Reuter U, Blumenfeld AM, Hutchinson S, Xia J, Miceli R, Severt L, Finnegan M, Trugman JM. Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial. Headache. 2023 Jan;63(1):79‐88. https://doi.org/10.1111/head.14439

The NCT number cited in the second sentence of the Methods section was incorrect. The correct number is NCT03700320.

We apologize for this error.